
2025年4月,注射用KH815臨床試驗申請獲得國家藥品監督管理局簽發的《藥物臨床試驗批準通知書》。隨著國
冠中生態:籌劃控製權變更事項股票停牌冠中生態公告,公司控股股東青島冠中投資集團有限公
Read More
There are many variations of passages of Lorem Ipsum available, but the majority have suffered alteration in some form, by injected humour.

There are many variations of passages of Lorem Ipsum available, but the majority have suffered alteration in some form, by injected humour.